tradingkey.logo
tradingkey.logo
Suchen

Zoetis Inc

ZTS
Zur Watchlist hinzufügen
76.050USD
-1.770-2.27%
Handelsschluss 06/26, 16:00ETKurse um 15 Minuten verzögert
32.32BMarktkapitalisierung
12.59KGV TTM

mehr Informationen über Zoetis Inc Unternehmen

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

Zoetis Inc Informationen

BörsenkürzelZTS
Name des UnternehmensZoetis Inc
IPO-datumFeb 01, 2013
CEOPeck (Kristin C)
Anzahl der mitarbeiter13800
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 01
Addresse10 Sylvan Way
StadtPARSIPPANY
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl07054
Telefon19738227000
Websitehttps://www.zoetis.com/
BörsenkürzelZTS
IPO-datumFeb 01, 2013
CEOPeck (Kristin C)

Führungskräfte von Zoetis Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
28.39K
+42.72%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.73K
+0.72%
Mr. Keith Sarbaugh
Mr. Keith Sarbaugh
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
3.35K
+30.01%
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
1.96K
-216.45%
Mr. Nicholas (Nick) Ashton
Mr. Nicholas (Nick) Ashton
Executive Vice President, President - Global Manufacturing and Supply
Executive Vice President, President - Global Manufacturing and Supply
1.82K
+39.96%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
28.39K
+42.72%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Zoetis Inc?

Die fünf größten Anteilseigner von Zoetis Inc sind: Ms. Kristin C. Peck

Was ist die größte Einnahmequelle von Zoetis Inc?

Am 2026Q4 erzielte das Geschäft mit Parasiticides für Zoetis Inc den höchsten Umsatz in Höhe von 2.34B, was 24.73% des Gesamtumsatzes entspricht.
KeyAI